CORE LABORATORIES INC.— Sankey Diagram
Quarterly mode · period ending 2026-03-31 · SEC EDGAR
ComparingFY2026 (Q4) vs FY2025 (Q4)
Revenue
$122M
↓-1.4% -$2Mvs FY2025 (Q4)
Gross Profit
$20M
↓-18.2% -$4Mvs FY2025 (Q4)
Operating Income
$2M
↓-57.3% -$3Mvs FY2025 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 (Q4) | FY2025 (Q4) |
|---|---|---|
| Revenue | $122M | $124M |
| COGS | $102M | $99M |
| Gross Profit | $20M | $24M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $4M | $4M |
| Other OpEx | $14M | $16M |
| Operating Income | $2M | $4M |
| Interest Exp. | $2M | $3M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $2M |
| Tax | $0 | $2M |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · CLB · Comparing FY2026 (Q4) vs FY2025 (Q4)